| abstract |
Disclosed herein are kinase inhibitory compounds, such as receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitory compounds. The compound may have a structure according to formula I . The disclosed compounds, pharmaceutical compositions and/or combinations can be used to treat or prevent kinase-related diseases or conditions, particularly RIP1-related diseases or conditions. |